TP53 and cardiovascular disorder: IS also induces cellular senescence via p53 activation in other cell types such as endothelial cells [30] and vascular smooth muscle cells [31], which implies involvement of IS in the progression of cardiovascular disease (CVD) in CKD patients, as has been suggested in several epidemiological studies [22, 23].